Baker Botts’ Top-Ranked Antitrust Practice Represents PetIQ in Purchase of Capstar from Elanco Animal Health Incorporated
WASHINGTON D.C., January 13, 2020 – Baker Botts L.L.P., a leading international law firm, announced today that its client PetIQ, Inc. (Nasdaq: PETQ), a leading pet medication and wellness company, has acquired Capstar®, an oral tablet that kills fleas in dogs and cats, from Elanco Animal Health Incorporated (NYSE: ELAN) in an all-cash $95 million deal.
To read the full PetIQ, Inc. press release, please click here.
The Baker Botts team was led by Antitrust Group Co-Chair Steve Weissman, assisted by Senior Associate Christine Ryu-Naya. Both are residents in the firm’s Washington D.C. office. Mr. Weissman previously served as Deputy Director for the FTC’s Bureau of Competition (2013-2015).
ABOUT BAKER BOTTS L.L.P.
Baker Botts is an international law firm whose lawyers practice throughout a network of offices around the globe. Based on our experience and knowledge of our clients' industries, we are recognized as a leading firm in the energy, technology and life sciences sectors. Since 1840, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit bakerbotts.com.